Praxis Precision Medicines, Inc. PRAX Cash Flow Statement
| TTM Q1 '26 | TTM Q4 '25 | TTM Q3 '25 | TTM Q2 '25 | TTM Q1 '25 | ||
|---|---|---|---|---|---|---|
| -$326.53M-53.6% | -$303.27M-65.9% | -$273.04M-80.8% | -$251.01M-103% | -$212.56M-69.5% | ||
| $132K-54.9% | $140K-60.9% | $159K-62.3% | $232K-47.2% | $293K-33.1% | ||
| $42.27M+18.5% | $33.94M-17.9% | $32.58M-15.4% | $37.56M+18.0% | $35.67M+12.4% | ||
| -$282.21M-72.2% | -$249.07M-89.0% | -$228.87M-130% | -$191.31M-101% | -$163.91M-65.3% | ||
| —— | —— | —— | $56K+12.0% | $0-100% | ||
| -$622.25M— | -$329.04M— | -$11.57M— | —— | —— | ||
| $1.26B+226% | $702.17M+36.5% | $203.42M-49.7% | $198.1M-50.9% | $385.84M+50.4% | ||
| $370.77M+1,715% | $141.96M+0.7% | -$19.12M— | $12.27M— | $20.42M— | ||
| -$282.33M-72.2% | -$249.12M-89.1% | -$228.92M-130% | -$191.36M-101% | -$163.91M-65.2% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How much cash does Praxis Precision Medicines, Inc. generate?
- Praxis Precision Medicines, Inc. (PRAX) generated -$282.2M in operating cash flow over the trailing twelve months.
- What is Praxis Precision Medicines, Inc.'s free cash flow?
- After $118.0K of capital expenditures, Praxis Precision Medicines, Inc.'s free cash flow was -$282.3M over the trailing twelve months, down 72.3% year over year.
- Where does Praxis Precision Medicines, Inc.'s cash flow data come from?
- Every line is extracted from Praxis Precision Medicines, Inc.'s SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.